DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/w5gftb/20142014_uk) has announced the addition of the "2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering.
The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.
The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
- Commercial/Private Labs
- Blood Banks
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Key Topics Covered:
- HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
- UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
- POTENTIAL MARKET ENTRY BARRIERS AND RISKS
- COMPETITIVE ASSESSMENTS
- Beckman Coulter/Danaher
- Becton Dickinson
- Eiken Chemical
- Enzo Biochem
- ID Biomedical/GSK
- Life Technology
- Novartis Diagnostics/Grifols
- Ortho-Clinical Diagnostics
- Takara Bio
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/w5gftb/20142014_uk.